Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Boceprevir Treatment in Liver Pre-transplant HCV Patients

NCT02160080 is registered in ClinicalTrials.gov with Hu Tsung-Hui as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02160080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Boceprevir Treatment in Liver Pre-transplant HCV Patients
Lead sponsor
Hu Tsung-Hui
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2014
Completion date
February 28, 2017
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

late complication from liver transplant